EN DE

Pee Cee Cosma Sope Limited (524136) Fair Value & Analysis

Consumer Goods · IN · Market cap ₹246M

PC Pee Cee Cosma Sope Limited 524136 · BSE
Price₹436.35
Fair Value₹515.36
Upside+18.1%
Quality67/100
Watch Pee Cee Cosma Sope Limited for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 4.6% net margin
Low debt · generates free cash flow
6.41% dividend yield
Moderate moat 48/100
Evidence: High Range ₹367.32 – ₹708.02 Share as image

Fair value as of: Aug 19, 2026

From 26 valuation models · updated today

A solid business, screening 18% undervalued on our models.

What matters now

  • A fairly wide model range (₹367.32 to ₹708.02) leaves room in how you read the outcome.
  • Our model range runs from ₹367.32 (bear) to ₹708.02 (bull), base ₹515.36. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 67/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹893.66 ₹87.87 Fair Value ₹515.36 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.

How to read this chart

60‑month range ₹87.87 – ₹893.66 · fair‑value band ₹367.32 – ₹708.02 · the ₹436.35 price screens below the ₹515.36 fair value. Dashed = 300-day average. As of Aug 19, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Pee Cee Cosma Sope Limited (524136) currently trades at ₹436.35, while our model-based Fair Value estimate is ₹515.36, implying the stock looks roughly 18.1% undervalued today. The Quality Score stands at 67/100 (solid quality), in the Consumer Goods sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Pee Cee Cosma Sope Limited generated revenue of ₹781M at a net margin of 4.6%. Revenue grew 19.4% year over year. It earns a return on equity of 14.7%. Net debt stands at ₹5.6M. Fundamentals as of Aug 19, 2026

Our scenario range runs from ₹367.32 (bear case) to ₹708.02 (bull case); at ₹436.35, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 21% below its 52-week high and 53% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Goods peers we cover trades at -57% fair-value upside, at 18%, 524136 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹471.19 ₹663.96 ₹904.69 80
Residual Income ₹188.85 ₹223.16 ₹448.00 76
Rev-Margin DCF ₹417.89 ₹642.06 ₹913.31 74
All 26 models by family
DCF Models
FCF DCF ₹474.08 ₹686.64 ₹967.21 38
Owner Earnings ₹318.24 ₹458.53 ₹643.71 31
5Y Revenue Exit ₹417.89 ₹640.16 ₹924.77 39
5Y EBITDA Exit ₹448.86 ₹700.22 ₹996.67 41
5Y P/E Exit ₹451.70 ₹705.73 ₹977.84 38
10Y Revenue Exit ₹427.31 ₹620.36 ₹883.72 36
10Y EBITDA Exit ₹453.30 ₹656.71 ₹932.21 37
10Y P/E Exit ₹454.88 ₹660.05 ₹919.51 35
Earnings-Based
Graham-Dodd ₹213.97 ₹791.95 ₹1,070 54
Lynch FV ₹189.87 ₹271.24 ₹352.61 50
PEG = 1.0 ₹189.87 ₹271.24 ₹352.61 46
EPV ₹283.30 ₹315.41 ₹341.48 59
Dividend Discount
Gordon GGM ₹20.90 ₹35.00 ₹45.43 70
DDM Multi-Stage ₹20.90 ₹33.20 ₹37.66 61
Multiples
P/E Multiple ₹472.00 ₹629.33 ₹786.66 63
P/S Multiple ₹401.20 ₹534.93 ₹668.66 58
P/B Multiple ₹401.20 ₹534.93 ₹668.66 55
EV/EBIT ₹577.67 ₹765.00 ₹952.33 53
EV/EBITDA ₹482.13 ₹637.61 ₹793.08 54
EV/Revenue ₹394.51 ₹556.86 ₹719.21 43
Asset-Based
NCAV (Graham) ₹106.03 ₹142.08 ₹212.05 50
Growth DCF
Growth DCF ₹471.19 ₹663.96 ₹904.69 80
Rev-Margin DCF ₹417.89 ₹642.06 ₹913.31 74
Economic Profit
Residual Income ₹188.85 ₹223.16 ₹448.00 76
ROIC Compounder ₹297.64 ₹355.35 ₹420.59 72
Growth Earnings
Growth-Adj P/E ₹343.30 ₹490.42 ₹637.55 68

Widest divergence: DCF Models (₹656.71) versus Dividend Discount (₹33.20). Highest evidence: Growth DCF (80).

Notify me when 524136 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹781M
Revenue growth (YoY) +19.4%
Net margin 4.6%
Return on equity 14.7%
Free cash flow ₹140M FY2026
P/E ratio 6.8 as of Jul 4, 2026
More key figures
Operating margin 6.3%
EPS (TTM) ₹13.66
Dividend yield 6.4%
EPS growth (YoY) +350%
Net debt ₹5.6M FY2025

Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 69 · Market factors (momentum, volatility) 40

Profitability 73
Margins and returns on capital today
Quality Growth 45
Are margins and returns improving?
Cashflow 68
Earnings quality: real cash, not paper profit
Fin. Strength 84
Balance sheet, leverage, solvency risk
Investment 49
Disciplined investing over empire-building
Low Volatility 24
Calm price path (market factor)
Momentum 49
Price trend over the last 3–12 months (market factor)
52W Momentum 43
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Pee Cee Cosma Sope Limited manufactures and sells soaps and detergents, cleaning and polishing preparations, perfumes, and toilet preparations in India. Its products primarily include detergent powders and cakes, and laundry soaps. The company offers its products through a network of distributors and retailers under the Doctor brand name.

Full company description

Pee Cee Cosma Sope Limited manufactures and sells soaps and detergents, cleaning and polishing preparations, perfumes, and toilet preparations in India. Its products primarily include detergent powders and cakes, and laundry soaps. The company offers its products through a network of distributors and retailers under the Doctor brand name. Pee Cee Cosma Sope Limited was founded in 1947 and is based in Agra, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Pee Cee Cosma Sope Limited reported revenue of ₹1.6B in FY2026 versus ₹927M in FY2022, a compound +14.3%/yr. Reported net income was ₹83.3M in FY2026, compounding +49.1%/yr from FY2022.

Growth Quality 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
₹1.6B
Latest YoY
+12.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.3%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.9%
Avg. growth/yr (12Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.3%
Revenue +14.3%/yr
FY22 ₹927M
FY23 ₹1.2B
FY24 ₹1.3B
FY25 ₹1.4B
FY26 ₹1.6B
Net income +49.1%/yr
FY22 ₹16.9M
FY23 ₹24.9M
FY24 ₹104M
FY25 ₹96.1M
FY26 ₹83.3M

Watch 524136: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Pee Cee Cosma Sope Limited Fair Value". https://www.fairvalue-calculator.com/stock/524136

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 57 · sector 0
FUTURE 97 · sector 0
PAST 59 · sector 0
HEALTH 100 · sector 0
DIVIDEND 100 · sector 0

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).

Stock Price Fair Value vs Fair Value
Godrej Consumer Products Limited 532424 ₹928.70 ₹329.76 -64%
Marico Limited 531642 ₹866.00 ₹200.14 -77%
Gillette India Limited 507815 ₹7,599 ₹1,674 -78%
Jyothy Labs Limited 532926 ₹199.85 ₹147.46 -26%
Ador Multiproducts Limited 523120 ₹74.86 ₹104.07 +39%
Hatsun Agro Product Limited 531531 ₹972.35 ₹362.14 -63%
Sundram Fasteners Limited 500403 ₹1,210 ₹240.89 -80%
EPL Limited 500135 ₹247.30 ₹111.65 -55%
V-Guard Industries Limited 532953 ₹343.45 ₹146.29 -57%
Finolex Industries Limited 500940 ₹158.35 ₹162.97 +3%

Compare Pee Cee Cosma Sope Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Pee Cee Cosma Sope Limited (524136) overvalued or undervalued?
As of Aug 19, 2026, our model estimates a fair value of ₹515.36 versus a price of ₹436.35, about +18% (undervalued).
What is the fair value of 524136?
Our model-based fair value for Pee Cee Cosma Sope Limited is ₹515.36 (as of Aug 19, 2026), built from audited fundamentals. The current price is ₹436.35.
What is the quality score of 524136?
Pee Cee Cosma Sope Limited has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Pee Cee Cosma Sope Limited (524136)?
Pee Cee Cosma Sope Limited reported trailing-twelve-month revenue of about ₹781M (latest available figure, as of Aug 19, 2026).
What is the net profit margin of 524136?
The net profit margin of Pee Cee Cosma Sope Limited is about 4.6%, meaning it keeps roughly 4.6% of revenue as net income. Based on the latest reported figures.
Does Pee Cee Cosma Sope Limited pay a dividend?
Pee Cee Cosma Sope Limited currently shows a dividend yield of about 6.41% relative to its recent price (as of Aug 19, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Pee Cee Cosma Sope Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.